We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+0.39%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$69.6B
AUM Growth
+$2.44B
Cap. Flow
+$2.78B
Cap. Flow %
4%
Top 10 Hldgs %
16.69%
Holding
760
New
59
Increased
405
Reduced
179
Closed
58

Top Buys

Rank Stock Value
1
AIG icon
American International
AIG
+$473M
2
HPQ icon
HP
HPQ
+$383M
3
OXY icon
Occidental Petroleum
OXY
+$349M
4
TGT icon
Target
TGT
+$343M
5
CI icon
Cigna
CI
+$229M

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Technology 15.47%
3 Healthcare 15.3%
4 Industrials 11.92%
5 Consumer Discretionary 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
26
RTX Corp
RTX
$282B
$644M 0.93%
9,224,579
+139,703
+2% +$10.3M
WDC icon
27
Western Digital
WDC
$192B
$633M 0.91%
10,680,554
+744,641
+7% +$53.3M
EMC
28
DELISTED
EMC CORPORATION
EMC
$633M 0.91%
23,981,296
-5,904,441
-20% -$157M
TSN icon
29
Tyson Foods
TSN
$20B
$598M 0.86%
14,023,481
+634,963
+5% +$26.1M
RTN
30
DELISTED
Raytheon Company
RTN
$562M 0.81%
5,870,625
+997,796
+20% +$105M
M icon
31
Macy's
M
$6.14B
$560M 0.8%
8,294,899
+152,800
+2% +$10.3M
GILD icon
32
Gilead Sciences
GILD
$162B
$556M 0.8%
4,748,165
+501,586
+12% +$54.8M
AON icon
33
Aon
AON
$76B
$552M 0.79%
5,534,738
+936,627
+20% +$93.7M
CB icon
34
Chubb
CB
$137B
$549M 0.79%
5,399,241
-161,872
-3% -$17.4M
EGN
35
DELISTED
Energen
EGN
$532M 0.76%
7,789,335
+988,249
+15% +$68.7M
LMT icon
36
Lockheed Martin
LMT
$131B
$520M 0.75%
2,799,543
-405,430
-13% -$78.1M
TEVA icon
37
Teva Pharmaceuticals
TEVA
$36.3B
$517M 0.74%
8,755,438
-238,262
-3% -$14.7M
BRCD
38
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$509M 0.73%
42,827,797
+1,533,233
+4% +$18.6M
DAL icon
39
Delta Air Lines
DAL
$53.9B
$491M 0.71%
11,954,349
+2,363,239
+25% +$103M
HPQ icon
40
HP
HPQ
$22.4B
$486M 0.7%
35,647,711
+25,800,801
+262% +$383M
TEL icon
41
TE Connectivity
TEL
$57.6B
$481M 0.69%
7,482,063
-1,369,161
-15% -$94.7M
AES icon
42
AES
AES
$10.6B
$466M 0.67%
35,121,723
+3,205,390
+10% +$43M
CCK icon
43
Crown Holdings
CCK
$12.5B
$462M 0.66%
8,726,318
+751,984
+9% +$41.4M
GPK icon
44
Graphic Packaging
GPK
$3.25B
$453M 0.65%
32,503,854
+3,911,802
+14% +$56.1M
EOG icon
45
EOG Resources
EOG
$77.5B
$442M 0.64%
5,051,056
+939,087
+23% +$86.8M
CMCSA icon
46
Comcast
CMCSA
$78.3B
$442M 0.64%
14,704,086
+1,954,682
+15% +$57.4M
ZBH icon
47
Zimmer Biomet
ZBH
$17.3B
$430M 0.62%
4,050,053
+767,542
+23% +$84.9M
ELV icon
48
Elevance Health
ELV
$82.3B
$410M 0.59%
2,495,556
+259,776
+12% +$41.5M
XL
49
DELISTED
XL Group Ltd.
XL
$398M 0.57%
10,692,286
+1,835,746
+21% +$68.8M
NXPI icon
50
NXP Semiconductors
NXPI
$70B
$398M 0.57%
4,049,105
+556,715
+16% +$57.1M

Similar funds

Boston Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Partners held 760 positions worth $69.6B, up 3.6% from $67.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners deployed $2.78B of net new capital in Q2 2015, opening 59 new positions and adding to 405 existing holdings. Its largest new stake was Target: 4,243,475 shares worth $346M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was OMNICARE INC, an estimated $333M trimmed.

  • Boston Partners's largest Q2 2015 buy was Target: 4,243,475 shares worth $346M.
  • Boston Partners added most to American International in Q2 2015, an estimated $473M increase.
  • Boston Partners's biggest Q2 2015 reduction was OMNICARE INC, cutting an estimated $333M.
  • Boston Partners fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $244M.
  • Boston Partners's ten largest holdings make up 17% of its $69.6B portfolio in Q2 2015.
  • Boston Partners opened 59 new positions and closed 58 in Q2 2015.
  • Boston Partners's portfolio value rose 3.6% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q2 2015, filed 10 Aug 2015.